December 6, 2023
  • Facebook
  • Twitter
  • LinkedIn

BiomolBiomed Viewpoints

Science in plain words

  • Home
  • News
  • About
    • BiomolBiomed Viewpoints
    • BiomolBiomed Journal
  • Journal Website
  • Reviews
  • pathology
  • microbiology
  • immunology
  • translational medicine
  • genetics
  • biochemistry
  • anatomy
  • molecular biology
  • clinical medicine
  • new methods
  • new medical entities
Latest posts
  • [ November 20, 2023 ] Setting New Standards with a CiteScore of 6.8 News
  • [ November 2, 2023 ] The Frontline of Cancer Warfare: CAR-T vs. CAR-Macrophage Therapies Author Summary
  • [ November 1, 2023 ] The Reviewer of the Month for November 2023: Emma Raitoharju, PhD Reviewer of the Month
  • [ October 18, 2023 ] The Promise of Roxadustat Author Summary
  • [ October 9, 2023 ] Revolutionizing Dementia Diagnosis: The Power of MRI Author Summary
Homeantidiabetic drugs

antidiabetic drugs

Gene variations can affect response to new antidiabetic drug classes
Author Summary

Gene variations can affect response to new antidiabetic drug classes

June 25, 2021 0

Type 2 diabetes (T2D) is the fastest growing health problem worldwide. Due to the development of modern technologies, a significant progress has been made in the last decade to understand the role of genetics in […]

VIDEO SUMMARIES

BiomolBiomed journal metrics

  • Impact Factor 2021 (JCR®): 3.76
  • CiteScore 2022 (Scopus): 5.3
  • Google Scholar Citations
  • Dimensions metrics

See more here…

pathriver logo
next generation pathology

BiomolBiomed Newsletters

Subscribe to receive the latest content and news from Biomolecules and Biomedicine. Choose from our sections or themes of your interest.

Categories

  • Author Summary
  • Conferences
  • Interview
  • News
  • Opinion
  • Reviewer of the Month
  • Topics
  • Video Summary

Archives

TELL US

What matters the most when choosing the journal to submit your article?
Vote
Follow us on Facebook

Copyright (c) 2021 Association of Basic Medical Sciences of FBIH

 

Loading Comments...